Speaking to The Washington Post Tuesday, Dr. Robert Nussbaum, Chief Medical Officer of Invitae, said the involvement of people who are not of European background in genetics research has been much more limited. “The result is that we don’t have as good a picture of the encyclopedia of what’s a damaging and not a damaging change in the genome of people who are not of European background,” Nussbuam said. “That’s a deficiency," Nussbaum noted that the NIH is very aware of this and is working to address that research gap.